Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global gastroenterology market size attained a value of USD 54.59 billion in 2023. The market is anticipated to grow at a CAGR of 6.2% during the forecast period of 2024-2032. The market is likely to attain a value of USD 93.80 billion by 2032, likely to be driven by the rising gastrointestinal cases across the globe.
A medical condition involving stomach and other organs of the digestive process are known as gastric conditions. The digestive system includes gastrointestinal tract, which is also known as the GI tract, comprising the esophagus, stomach, small intestine, large intestine, and the accessory organs of digestion, which include the pancreas, gallbladder, and liver. The branch of medicine which deals with the examination, diagnosis, and treatment of the issues related to these parts is known as gastroenterology.
In order to move material through the GI tract, digest it, absorb nutrients for use by the body, and remove waste from the body through defecation, the digestive system must function efficiently. Due to the similarity of many of the symptoms and the time-consuming nature of the diagnostic procedures, diagnosing a gastrointestinal illness may be difficult.
The increasing awareness among people about the importance of early diagnosis of gastrointestinal disorders and about available treatments is directly influencing the market growth. The increasing shift towards minimally invasive surgical procedures is also driving the market growth as people are preferring them more among other approaches. The continuous development in the diagnosis procedure of gastrointestinal disorders is also propelling the market growth.
The integration and development of technologically advanced imaging techniques, such as fluoroscopy, is also adding up significant growth to the overall gastroenterology market share. The continuous development of endoscopy devices is anticipated to accelerate the market growth further. The increasing preference for personalized treatment approaches is also expected to drive the market demand as a personalized molecular diagnosis will enable the healthcare professional to retrieve more useful diagnosis data for individuals, with the ability to produce a personalized prognosis and treatment approaches.
The increasing number of approvals is also expected to escalate the market growth. For example, the Vowst has been approved by the FDA as the first oral microbiota biotherapeutic for recurrent C. difficile infection in adults, following antibacterial treatment. The increasing government initiatives towards accessible healthcare is also aiding the growth of the market. The first drug to cure functional constipation in children and the first oral product to cure moderately to severely active Crohn’s disease has also been approved by the FDA recently, further escalating the global gastroenterology market development. There has been a surge in the market due to increase in development and manufacturing gastrointestinal drugs globally, which is further anticipated to propel the market growth. Various drugs are currently in the pipeline to be approved, including 16 oral drugs and six injectables in the pipeline. There are six drugs for breast cancer and three for non-small cell lung cancer (NSCLC) in the pipeline. Once approved, these drugs can potentially improve the treatment landcape.
Market Breakup by Product Type
Market Breakup by Indications
Market Breakup by End User
Market Breakup by Region
The market is experiencing significant growth due to the rising prevalence of pancreatic disorders across the globe. People are adapting to sedentary lifestyle, including unhealthy eating habits and non-active lifestyle, which leads to digestion issues, gastrointestinal issues, among others. The increasing numbers of gastrointestinal disorders are likely to drive the market growth further in the coming years.
The growth of the market is also driven by the increasing geriatric population as with growing age they get more susceptible to them due to weakened immune system. The increasing healthcare expenditure of countries globally is also driving the global gastroenterology market growth as the patient pool is large. The increasing demand for more cost effective and accessible treatments for gastrointestinal disorders such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and colorectal cancer, is a key factor influencing the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Indications |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 6.2% during the forecast period of 2024-2032.
The increasing number of gastrointestinal disorders and increasing healthcare expenditure among people across the globe is a major factor driving the market growth.
The increasing technological development and increased approvals for new drugs in the pipeline are among major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The types of gastroenterology products include drugs, medical devices, and diagnostic tools, among others.
The indications include inflammatory bowel disease (IBD) and gastroesophageal reflux disease (GERD), colorectal cancer, liver diseases, and pancreatic disorders, among others.
The end users in the market include hospitals, ambulatory surgical centers, specialty clinics, and research institutes, among others.
Key players involved in the market are Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc., ALLERGAN, AstraZeneca, Astellas Pharma US, Inc., Pfizer Inc., and Takeda Pharmaceutical Company Limited
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share